Letter: Bone resorption by breast-cancer tissue

Advances in the treatment of cytomegalovirus.

British medical bulletin·2019

LPS promotes a monocyte phenotype permissive for human cytomegalovirus immediate-early gene expression upon infection but not reactivation from latency.

Scientific reports·2017

The recombinant protein rSP03B is a valid antigen for screening dog exposure to Phlebotomus perniciosus across foci of canine leishmaniasis.

Medical and veterinary entomology·2016

Transient activation of human cytomegalovirus lytic gene expression during latency allows cytotoxic T cell killing of latently infected cells.

Scientific reports·2016

Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells.

Journal of virology·2014

Analysis of cytotoxic T-cell responses to human cytomegalovirus infection.

Methods in molecular medicine·2011

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Disrupting Bacterial Quorum Sensing: A Review of Protein Families and Natural Inhibitors for Combating Resistance.

Current topics in medicinal chemistry·2026

Design, Optimization and Physicochemical Characterization of Pectin-Based Nanoparticles for In Vitro Anticancer Evaluation Against HCT116 Colon Cancer Cells.

Current pharmaceutical design·2026

Integrative bioinformatics and in vivo validation suggest a potential role of <i>Cbr4</i> in alcohol use disorder through modulation of lipid metabolism and treg cell function in the central amygdala.

Frontiers in genetics·2026

Research progress of cuproptosis, ferroptosis, apoptosis, and autophagy in knee osteoarthritis.

Frontiers in cell and developmental biology·2026

Integrating multi-omics and machine learning to uncover CCL20 as a potential regulator of the immunosuppressive microenvironment in lung adenocarcinoma.

Frontiers in immunology·2026

Uncovering cellular perturbations and key mediator communications in liver cancer using single-cell RNA sequencing.

Frontiers in immunology·2026

Related Experiment Videos

Letter: Bone resorption by breast-cancer tissue

Related Concept Videos

Advances in the treatment of cytomegalovirus.

LPS promotes a monocyte phenotype permissive for human cytomegalovirus immediate-early gene expression upon infection but not reactivation from latency.

The recombinant protein rSP03B is a valid antigen for screening dog exposure to Phlebotomus perniciosus across foci of canine leishmaniasis.

Transient activation of human cytomegalovirus lytic gene expression during latency allows cytotoxic T cell killing of latently infected cells.

Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells.

Analysis of cytotoxic T-cell responses to human cytomegalovirus infection.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Disrupting Bacterial Quorum Sensing: A Review of Protein Families and Natural Inhibitors for Combating Resistance.

Design, Optimization and Physicochemical Characterization of Pectin-Based Nanoparticles for In Vitro Anticancer Evaluation Against HCT116 Colon Cancer Cells.

Integrative bioinformatics and in vivo validation suggest a potential role of <i>Cbr4</i> in alcohol use disorder through modulation of lipid metabolism and treg cell function in the central amygdala.

Research progress of cuproptosis, ferroptosis, apoptosis, and autophagy in knee osteoarthritis.

Integrating multi-omics and machine learning to uncover CCL20 as a potential regulator of the immunosuppressive microenvironment in lung adenocarcinoma.

Uncovering cellular perturbations and key mediator communications in liver cancer using single-cell RNA sequencing.

Related Experiment Videos

Letter: Bone resorption by breast-cancer tissue

Related Concept Videos

Related Articles